Amyloidosis is a group of rare diseases in which misfolded aggregates of protein (amyloid) accumulate in tissues and organs. The currently available amyloidosis treatments provide symptomatic relief and palliative care. These include chemotherapy, targeted therapy, supportive therapy, surgery and stem cell transplantation. High-dose chemotherapy followed by autologous stem cell transplantation remains the preferred therapy for low-risk patients in the United States due to the high hematologic remission rate and long-term disease control after treatment.
Market Overview and Trends
The global market for amyloidosis treatment is expected to increase during the forecast period from 2019-2029. Targeted therapies and stem cell transplants are catching on in developed countries. However, most of the world’s population does not have access to sufficient health infrastructure to ensure rapid diagnosis and treatment in low-income economies. Furthermore, one of the biggest challenges for the amyloidosis treatment market is the high cost of these therapies, which creates a financial burden for patients based in underdeveloped regions. Targeted therapy is likely to show the fastest growth in the global market, followed by stem cell transplantation and surgery. Chemotherapy and supportive care are expected to have stable share in the forecast period.
Factors Influencing the Market Growth:
• Rise in geriatric population
• Increase in transplantation globally
• Rise in awareness regarding the benefits of these products
Factors Restraining the Market Growth:
• Lack of skilled/experienced professionals
• High cost of the therapies
Market Segmentation 2019-2029:
The Amyloidosis Treatment market is segmented by Treatment (Stem Cell Transplant, Chemotherapy, Supportive Care, Surgery, Targeted Therapy), By Country, And Segment Forecasts.
Market Segmentation Covered:
• Global Amyloidosis Market – Treatments Market 2019-2029
– Global Chemotherapy Market 2019-2029
– Global Supportive Care Market 2019-2029
– Global Surgery Market 2019-2029
– Global Stem Cell Transplant Market 2019-2029
– Global Targeted Therapy Market 2019-2029
Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029
Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Amyloidosis Treatment market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
Major Market Players:
Pfizer, Inc.; Ionis Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Ltd.; Johnson and Johnson Pvt. Ltd.; and Alnylam Pharmaceuticals, Inc.
Key questions answered by this report:
• What is the current size of the total global Amyloidosis Treatment market?
• How much will this market be worth from 2018 to 2029?
• How is the Amyloidosis Treatment market evolving?
• What is driving and restraining the Amyloidosis Treatment market?
• What are the market shares of each segment of the overall Amyloidosis Treatment market currently and how will these change to 2029?
• What are the main submarkets and how much revenue will each Amyloidosis Treatment market submarket account for over the next 10 years to 2029 and why?
• How will the market shares for each Amyloidosis Treatment market submarket develop from 2018 to 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve to 2029?
• What are the largest national markets for Amyloidosis Treatment market? What is the current status and how will it develop over the next ten years? What are their forecasts for 2019-2029?
• Who are the most prominent companies, and what are their activities and outlooks?
• What are the main trends that will affect the Amyloidosis Treatment market between 2018 and 2029?
Visiongain’s study is intended for anyone requiring commercial analyses for the Amyloidosis Treatment market. You find data, trends and predictions.
Buy our report today Amyloidosis Treatment Market 2019-2029: By Treatment (Stem Cell Transplant, Chemotherapy, Supportive Care, Surgery, Targeted Therapy), By Country, And Segment Forecasts.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1 Report Overview
1.1 Global Amyloidosis Treatment Market
1.2 Global Amyloidosis Treatment Market Overview
1.3 Global Amyloidosis Treatment Market Segmentation
1.4 Market Drivers
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report Include:
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2 Introduction to the Amyloidosis Treatment Market
2.1 Global Amyloidosis Market - Treatments
2.1.1 Chemotherapy
2.1.2 Supportive Care
2.1.3 Surgery
2.1.4 Stem Cell Transplant
2.1.5 Targeted Therapy
3 Global Amyloidosis Treatment Market Analysis
3.1 PEST Analysis of the Amyloidosis Treatment Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Amyloidosis Treatment Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Amyloidosis Treatment Overall Operating Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Amyloidosis Treatment Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
4 Amyloidosis Treatment: Global Market
1.1 Global Amyloidosis Market - Treatments Market 2019-2029
1.1.1 Global Chemotherapy Market 2019-2029
1.1.2 Global Supportive Care Market 2019-2029
1.1.3 Global Surgery Market 2019-2029
1.1.4 Global Stem Cell Transplant Market 2019-2029
1.1.5 Global Targeted Therapy Market 2019-2029
5 Leading Regions in Amyloidosis Treatment Market 2019-2029
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia-Pacific
5.1.4 Middle East & Africa
5.1.5 Rest of the World
5.1.6 Leading Countries/ Regions by Amyloidosis Treatment Market
5.2 Canada Amyloidosis Treatment Market 2019-2029
5.2.1 Canada Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.2.2 Canada Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.2.3 Canada Amyloidosis Treatment Market Analysis
5.3 U.S. Amyloidosis Treatment Market 2019-2029
5.3.1 U.S. Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.3.2 U.S. Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.3.3 U.S. Amyloidosis Treatment Market Analysis
5.4 Germany Amyloidosis Treatment Market 2019-2029
5.4.1 Germany Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.4.2 Germany Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.4.3 Germany Amyloidosis Treatment Market Analysis
5.5 France Amyloidosis Treatment Market 2019-2029
5.5.1 France Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.5.2 France Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.5.3 France Amyloidosis Treatment Market Analysis
5.6 U.K. Amyloidosis Treatment Market 2019-2029
5.6.1 U.K. Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.6.2 U.K. Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.6.3 U.K. Amyloidosis Treatment Market Analysis
5.7 Italy Amyloidosis Treatment Market 2019-2029
5.7.1 Italy Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.7.2 Italy Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.7.3 Italy Amyloidosis Treatment Market Analysis
5.8 Spain Amyloidosis Treatment Market 2019-2029
5.8.1 Spain Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.8.2 Spain Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.8.3 Spain Amyloidosis Treatment Market Analysis
5.9 China Amyloidosis Treatment Market 2019-2029
5.9.1 China Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.9.2 China Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.9.3 China Amyloidosis Treatment Market Analysis
5.10 Australia Amyloidosis Treatment Market 2019-2029
5.10.1 Australia Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.10.2 Australia Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.10.3 Australia Amyloidosis Treatment Market Analysis
5.11 India Amyloidosis Treatment Market 2019-2029
5.11.1 India Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.11.2 India Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.11.3 India Amyloidosis Treatment Market Analysis
5.12 Indonesia Amyloidosis Treatment Market 2019-2029
5.12.1 Indonesia Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.12.2 Indonesia Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.13 India Amyloidosis Treatment Market 2019-2029
5.13.1 India Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.13.2 India Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.13.3 India Amyloidosis Treatment Market Analysis
5.14 South Korea Amyloidosis Treatment Market 2019-2029
5.14.1 5.13.1 South Korea Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.14.2 South Korea Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.14.3 South Korea Amyloidosis Treatment Market Analysis
5.15 Rest of Asia Amyloidosis Treatment Market 2019-2029
5.15.1 Rest of Asia Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.15.2 Rest of Asia Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.15.3 Rest of Asia Amyloidosis Treatment Market Analysis
5.16 Middle East Amyloidosis Treatment Market 2019-2029
5.16.1 Middle East Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.16.2 Middle East Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.16.3 Middle East Amyloidosis Treatment Market Analysis
5.17 Africa Amyloidosis Treatment Market 2019-2029
5.17.1 Africa Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.17.2 Africa Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.17.3 Africa Amyloidosis Treatment Market Analysis
5.18 Rest of the World Amyloidosis Treatment Market 2019-2029
5.18.1 Rest of the World Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
5.18.2 Rest of the World Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
5.18.3 Rest of the World Amyloidosis Treatment Market Analysis
6 Leading Companies in the Amyloidosis Treatment Market
6.1 Pfizer, Inc.
6.1.1 Company Overview
6.1.2 Product And Services Overview
6.1.3 Financials Overview
6.1.4 Key Developments
6.1.5 SWOT Analysis
6.2 Ionis Pharmaceuticals, Inc.
6.2.1 Company Overview
6.2.2 Product And Services Overview
6.2.3 Financial Overview
6.2.4 Key Developments
6.2.5 SWOT Analysis
6.3 Takeda Pharmaceutical Company Ltd.
6.3.1 Company Overview
6.3.2 Product And Services Overview
6.3.3 Financial Overview
6.3.4 Key Development
6.3.5 SWOT Analysis
6.4 Johnson and Johnson Pvt. Ltd.
6.4.1 Company Overview
6.4.2 Product And Services Overview
6.4.3 Financial Overview
6.4.4 Key Development
6.4.5 SWOT Analysis
6.5 Alnylam Pharmaceuticals, Inc.
6.5.1 Company Overview
6.5.2 Product And Services Overview
6.5.3 Financial Overview
6.5.4 Key Developments
6.5.5 SWOT Analysis
6.6 GlaxoSmithKline Pharmaceuticals Ltd.
6.6.1 Company Overview
6.6.2 Product And Services Overview
6.6.3 Financial Overview
6.6.4 Key Developments
6.6.5 SWOT Analysis
6.7 Celgene Corp
6.7.1 Overview
6.7.2 Product And Services Overview
6.7.3 Financial Overview
6.7.4 Key Developments
6.7.5 SWOT Analysis
6.8 Eidos Therapeutics
6.8.1 Overview
6.8.2 Product And Services Overview
6.8.3 Financials
6.8.4 Key Developments
6.8.5 SWOT Analysis
6.9 Corino Therapeutics, Inc.
6.9.1 Overview
6.9.2 Product And Services Overview
6.9.3 Financials
6.9.4 Key Developments
6.9.5 SWOT Analysis
6.10 Spectrum Pharmaceuticals, Inc.
6.10.1 Overview
6.10.2 Product And Services Overview
6.10.3 Financials
6.10.4 Key Developments
6.10.5 SWOT Analysis
7 Conclusions and Recommendations
7.1 Global Amyloidosis Treatment Market Outlook
7.2 Recommendations
8 Glossary
8.1 Associated Visiongain Reports
8.2 Visiongain Report Sales Order Form
8.3 Appendix A
8.4 About Visiongain
8.5 Appendix B
8.6 Visiongain Report Evaluation Form
List of Tables
Table 3.1 PEST Analysis of the Amyloidosis Treatment Market
Table 3.8 SWOT Analysis of the Amyloidosis Treatment Market
Table 1.1 Global Amyloidosis Market - Treatments Market 2019-2029
Table 1.1.1 Global Chemotherapy Market 2019-2029
Table 1.1.2 Global Supportive Care Market 2019-2029
Table 1.1.3 Global Surgery Market 2019-2029
Table 1.1.4 Global Stem Cell Transplant Market 2019-2029
Table 1.1.5 Global Targeted Therapy Market 2019-2029
Table 5.2 Canada Amyloidosis Treatment Market 2019-2029
Table 5.2.1 Canada Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.2.2 Canada Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.2.3 Canada Amyloidosis Treatment Market Analysis
Table 5.3 U.S. Amyloidosis Treatment Market 2019-2029
Table 5.3.1 U.S. Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.3.2 U.S. Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.3.3 U.S. Amyloidosis Treatment Market Analysis
Table 5.4 Germany Amyloidosis Treatment Market 2019-2029
Table 5.4.1 Germany Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.4.2 Germany Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.4.3 Germany Amyloidosis Treatment Market Analysis
Table 5.5 France Amyloidosis Treatment Market 2019-2029
Table 5.5.1 France Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.5.2 France Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.5.3 France Amyloidosis Treatment Market Analysis
Table 5.6 U.K. Amyloidosis Treatment Market 2019-2029
Table 5.6.1 U.K. Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.6.2 U.K. Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.6.3 U.K. Amyloidosis Treatment Market Analysis
Table 5.7 Italy Amyloidosis Treatment Market 2019-2029
Table 5.7.1 Italy Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.7.2 Italy Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.7.3 Italy Amyloidosis Treatment Market Analysis
Table 5.8 Spain Amyloidosis Treatment Market 2019-2029
Table 5.8.1 Spain Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.8.2 Spain Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.8.3 Spain Amyloidosis Treatment Market Analysis
Table 5.9 China Amyloidosis Treatment Market 2019-2029
Table 5.9.1 China Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.9.2 China Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.9.3 China Amyloidosis Treatment Market Analysis
Table 5.10 Australia Amyloidosis Treatment Market 2019-2029
Table 5.10.1 Australia Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.10.2 Australia Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.10.3 Australia Amyloidosis Treatment Market Analysis
Table 5.11 India Amyloidosis Treatment Market 2019-2029
Table 5.11.1 India Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.11.2 India Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.11.3 India Amyloidosis Treatment Market Analysis
Table 5.12 Indonesia Amyloidosis Treatment Market 2019-2029
Table 5.12.1 Indonesia Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.12.2 Indonesia Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.13 India Amyloidosis Treatment Market 2019-2029
Table 5.13.1 India Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.13.2 India Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.13.3 India Amyloidosis Treatment Market Analysis
Table 5.14 South Korea Amyloidosis Treatment Market 2019-2029
Table 5.14.1 5.13.1 South Korea Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.14.2 South Korea Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.14.3 South Korea Amyloidosis Treatment Market Analysis
Table 5.15 Rest of Asia Amyloidosis Treatment Market 2019-2029
Table 5.15.1 Rest of Asia Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.15.2 Rest of Asia Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.15.3 Rest of Asia Amyloidosis Treatment Market Analysis
Table 5.16 Middle East Amyloidosis Treatment Market 2019-2029
Table 5.16.1 Middle East Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.16.2 Middle East Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.16.3 Middle East Amyloidosis Treatment Market Analysis
Table 5.17 Africa Amyloidosis Treatment Market 2019-2029
Table 5.17.1 Africa Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.17.2 Africa Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.17.3 Africa Amyloidosis Treatment Market Analysis
Table 5.18 Rest of the World Amyloidosis Treatment Market 2019-2029
Table 5.18.1 Rest of the World Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Table 5.18.2 Rest of the World Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Table 5.18.3 Rest of the World Amyloidosis Treatment Market Analysis
Table 6.1.3 Pfizer, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.1.5 Pfizer, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.2.3 Ionis Pharmaceuticals, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.2.5 Ionis Pharmaceuticals, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.3.3 Takeda Pharmaceutical Company Ltd. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.3.5 Takeda Pharmaceutical Company Ltd. Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.4.3 Johnson and Johnson Pvt. Ltd. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.4.5 Johnson and Johnson Pvt. Ltd. Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.5.3 Alnylam Pharmaceuticals, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.5.5 Alnylam Pharmaceuticals, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.6.3 GlaxoSmithKline Pharmaceuticals Ltd. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.6.5 GlaxoSmithKline Pharmaceuticals Ltd. Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.7.3 Celgene Corp Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.7.5 Celgene Corp Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.8.3 Eidos Therapeutics Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.8.5 Eidos Therapeutics Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.9.3 Corino Therapeutics, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.9.5 Corino Therapeutics, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.10.3 Spectrum Pharmaceuticals, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.10.5 Spectrum Pharmaceuticals, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
List of Figures
Figure 1.1 Global Amyloidosis Treatment Market Segmentation
Figure 1.1 Global Amyloidosis Market - Treatments Market 2019-2029
Figure 1.1.1 Global Chemotherapy Market 2019-2029
Figure 1.1.2 Global Supportive Care Market 2019-2029
Figure 1.1.3 Global Surgery Market 2019-2029
Figure 1.1.4 Global Stem Cell Transplant Market 2019-2029
Figure 1.1.5 Global Targeted Therapy Market 2019-2029
Figure 5.2 Canada Amyloidosis Treatment Market 2019-2029
Figure 5.2.1 Canada Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.2.2 Canada Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.2.3 Canada Amyloidosis Treatment Market Analysis
Figure 5.3 U.S. Amyloidosis Treatment Market 2019-2029
Figure 5.3.1 U.S. Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.3.2 U.S. Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.3.3 U.S. Amyloidosis Treatment Market Analysis
Figure 5.4 Germany Amyloidosis Treatment Market 2019-2029
Figure 5.4.1 Germany Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.4.2 Germany Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.4.3 Germany Amyloidosis Treatment Market Analysis
Figure 5.5 France Amyloidosis Treatment Market 2019-2029
Figure 5.5.1 France Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.5.2 France Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.5.3 France Amyloidosis Treatment Market Analysis
Figure 5.6 U.K. Amyloidosis Treatment Market 2019-2029
Figure 5.6.1 U.K. Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.6.2 U.K. Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.6.3 U.K. Amyloidosis Treatment Market Analysis
Figure 5.7 Italy Amyloidosis Treatment Market 2019-2029
Figure 5.7.1 Italy Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.7.2 Italy Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.7.3 Italy Amyloidosis Treatment Market Analysis
Figure 5.8 Spain Amyloidosis Treatment Market 2019-2029
Figure 5.8.1 Spain Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.8.2 Spain Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.8.3 Spain Amyloidosis Treatment Market Analysis
Figure 5.9 China Amyloidosis Treatment Market 2019-2029
Figure 5.9.1 China Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.9.2 China Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.9.3 China Amyloidosis Treatment Market Analysis
Figure 5.10 Australia Amyloidosis Treatment Market 2019-2029
Figure 5.10.1 Australia Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.10.2 Australia Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.10.3 Australia Amyloidosis Treatment Market Analysis
Figure 5.11 India Amyloidosis Treatment Market 2019-2029
Figure 5.11.1 India Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.11.2 India Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.11.3 India Amyloidosis Treatment Market Analysis
Figure 5.12 Indonesia Amyloidosis Treatment Market 2019-2029
Figure 5.12.1 Indonesia Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.12.2 Indonesia Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.13 India Amyloidosis Treatment Market 2019-2029
Figure 5.13.1 India Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.13.2 India Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.13.3 India Amyloidosis Treatment Market Analysis
Figure 5.14 South Korea Amyloidosis Treatment Market 2019-2029
Figure 5.14.1 5.13.1 South Korea Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.14.2 South Korea Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.14.3 South Korea Amyloidosis Treatment Market Analysis
Figure 5.15 Rest of Asia Amyloidosis Treatment Market 2019-2029
Figure 5.15.1 Rest of Asia Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.15.2 Rest of Asia Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.15.3 Rest of Asia Amyloidosis Treatment Market Analysis
Figure 5.16 Middle East Amyloidosis Treatment Market 2019-2029
Figure 5.16.1 Middle East Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.16.2 Middle East Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.16.3 Middle East Amyloidosis Treatment Market Analysis
Figure 5.17 Africa Amyloidosis Treatment Market 2019-2029
Figure 5.17.1 Africa Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.17.2 Africa Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.17.3 Africa Amyloidosis Treatment Market Analysis
Figure 5.18 Rest of the World Amyloidosis Treatment Market 2019-2029
Figure 5.18.1 Rest of the World Amyloidosis Treatment Submarket, By Treatments (Chemotherapy, Supportive care, Surgery, Stem cells Transplant) Forecast 2019-2029
Figure 5.18.2 Rest of the World Amyloidosis Treatment Submarket, By Treatments (Targeted Therapy) Forecast 2019-2029
Figure 5.18.3 Rest of the World Amyloidosis Treatment Market Analysis
Figure 6.1.3 Pfizer, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.1.5 Pfizer, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.2.3 Ionis Pharmaceuticals, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.2.5 Ionis Pharmaceuticals, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.3.3 Takeda Pharmaceutical Company Ltd. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.3.5 Takeda Pharmaceutical Company Ltd. Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.4.3 Johnson and Johnson Pvt. Ltd. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.4.5 Johnson and Johnson Pvt. Ltd. Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.5.3 Alnylam Pharmaceuticals, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.5.5 Alnylam Pharmaceuticals, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.6.3 GlaxoSmithKline Pharmaceuticals Ltd. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.6.5 GlaxoSmithKline Pharmaceuticals Ltd. Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.7.3 Celgene Corp Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.7.5 Celgene Corp Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.8.3 Eidos Therapeutics Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.8.5 Eidos Therapeutics Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.9.3 Corino Therapeutics, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.9.5 Corino Therapeutics, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.10.3 Spectrum Pharmaceuticals, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.10.5 Spectrum Pharmaceuticals, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Alnylam Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Johnson and Johnson Pvt. Ltd.
Pfizer, Inc.
Takeda Pharmaceutical Company Ltd.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
